Developing Objective Fatigue Indicators in Colorectal Cancer Survivors.
|ClinicalTrials.gov Identifier: NCT01700283|
Recruitment Status : Unknown
Verified October 2012 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : October 4, 2012
Last Update Posted : November 14, 2012
The aims of this four-year study are to
- Explore exercise behavior, exercise barriers, and identify the significant factors for exercise behavior in colorectal cancer survivors.
- Explore the relationships among fatigue, muscle strength, and metabolomics and further examine the possible biomarkers from muscle strength and metabolomics for fatigue.
- Develop a clinical guidelines of home-based fatigue management and exercise program and test its effect on decreasing fatigue for patients with colorectal cancer after surgery in Taiwan.
|Condition or disease||Intervention/treatment|
|Colorectal Cancer||Behavioral: exercise education and walking program|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||306 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Developing Objective Fatigue Indicators: Exploring the Relationships Among Fatigue, Muscle Power and Metabolomics Through Fatigue Management and Individualized Exercise Education Program in Colorectal Cancer Survivors.|
|Study Start Date :||October 2012|
|Estimated Primary Completion Date :||July 2015|
|Estimated Study Completion Date :||July 2015|
|Experimental: exercise education and walking program||
Behavioral: exercise education and walking program
12-week moderate intensity walking program
|No Intervention: maintain their daily activity|
- Developing Objective Fatigue Indicators: Exploring the Relationships Among Fatigue, Muscle Power and Metabolomics Through Fatigue Management and Individualized Exercise Education Program in Colorectal Cancer Survivors [ Time Frame: four-year study ]Develope the clinical exercise education program guideline for patients with early stage colorectal cancer survivor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01700283
|Contact: Shiow-Ching Shun, PHD||886-2-23123456 ext firstname.lastname@example.org|
|National Taiwan University Hospital||Recruiting|
|Contact: Shiow-Ching Shun, PHD 886-2-2312-3456 ext 88439 email@example.com|
|Principal Investigator: Shiow-Ching Shun, PHD|
|Principal Investigator:||Shiow-Ching Shun, PhD||National Taiwan University|